Zero-fluoroscopic Navigation Versus Conventional Fluoroscopic Navigation for Single-chamber Pacemaker Implantation (ZF-PMSC)
Multi-center, Randomized, Controlled Trial to Compare Feasibility, Safety and Efficacy of Zero-Fluoroscopic Navigation With Conventional Fluoroscopic Navigation for Single-chamber Pacemaker Implantation
Sponsor: First Affiliated Hospital of Guangxi Medical University
This NA trial investigates Bradycardia and Complete Atrioventricular Block and is currently ongoing. First Affiliated Hospital of Guangxi Medical University leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Dec 2019 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2017 — Dec 2019 [monthly]
Recruiting NA
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- First Affiliated Hospital of Guangxi Medical University
- Fu Wai Hospital, Beijing, China
- Guangdong Provincial People's Hospital
- Ningbo No. 1 Hospital
- Shenzhen Sun Yat-sen Cardiovascular Hospital
- Tongji Hospital
- Wuhan Asia Heart Hospital
- Xinyang Central Hospital
For direct contact, visit the study record on ClinicalTrials.gov .